{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:53:46Z","timestamp":1791615226877,"version":"4.3.4"},"reference-count":53,"publisher":"Wiley","issue":"14","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001543","name":"Neurological Foundation of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["physoc.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Physiology"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>\n                      Duchenne muscular dystrophy (DMD) is a multisystem disorder affecting striated muscle, metabolism and the central nervous system (CNS). Although glucocorticoids remain the standard therapy, muscle\u2010centric evaluations typically fail to capture how dosing regimen and compound selection affect CNS and metabolic phenotypes. Here, we compared daily and weekly dosing of prednisolone and vamorolone in juvenile\n                      <jats:italic>mdx<\/jats:italic>\n                      mice over 6\u00a0weeks to determine how these variables influence multisystem outcomes. Multiorgan efficacy and adverse effects were quantified across behavioural, endocrine, metabolic, cardiovascular and muscle domains using behavioural assays,\n                      <jats:italic>in vivo<\/jats:italic>\n                      and functional muscle testing, haemodynamic evaluation and histopathology. Daily glucocorticoid dosing failed to improve muscle function or strength, whereas weekly vamorolone produced the most robust improvements in functional and\n                      <jats:italic>in vivo<\/jats:italic>\n                      muscle strength. Daily prednisolone reduced circulating creatine kinase levels, but this biochemical change did not translate into enhanced muscle function outcomes. Daily regimens also induced severe adrenal cortical atrophy, yet these endocrine alterations were dissociated from CNS stress and anxiety responses, which remained unchanged by treatment. In addition, daily dosing caused pronounced systemic metabolic consequences, whereas weekly regimens substantially attenuated these effects, identifying dosing frequency as a key determinant of safety. Together, these findings demonstrate that glucocorticoid regimen selection fundamentally reshapes the efficacy\n                      <jats:italic>versus<\/jats:italic>\n                      adverse effect profile and underscores the value of integrated multiorgan evaluation in DMD. This work highlights the need to expand therapeutic assessments beyond muscle pathology and raises new questions about how glucocorticoid signalling differentially engages peripheral and central physiological systems.\n                      <jats:boxed-text content-type=\"graphic\" position=\"anchor\">\n                        <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" mimetype=\"image\/png\" position=\"anchor\" specific-use=\"enlarged-web-image\" xlink:href=\"graphic\/tjp70630-gra-0001-m.png\">\n                          <jats:alt-text>image<\/jats:alt-text>\n                        <\/jats:graphic>\n                      <\/jats:boxed-text>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Duchenne muscular dystrophy affects multiple physiological systems, yet current glucocorticoid assessments rarely capture the CNS and metabolic effects of dosing regimens.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Weekly vamorolone dosing improved muscle strength in\n                            <jats:italic>mdx<\/jats:italic>\n                            mice, while daily prednisolone failed to improve performance despite lowering plasma creatine kinase.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Stress\u2010 and anxiety\u2010related behaviours remained unchanged, despite adrenal atrophy revealing a disconnect between peripheral endocrine disruption and CNS phenotypes.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Daily glucocorticoid regimens triggered endocrine and metabolic side effects, whereas weekly dosing reduced these effects.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Prednisolone and vamorolone produced broadly similar systemic side\u2010effect profiles, but dosing frequency was the primary determinant of their severity.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1113\/jp291378","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:55:58Z","timestamp":1780030558000},"page":"5984-6008","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regimen\u2010dependent glucocorticoid effects improve muscle performance without altering CNS physiology in\n                    <i>mdx<\/i>\n                    mice"],"prefix":"10.1113","volume":"604","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4275-4199","authenticated-orcid":false,"given":"Gretel S.","family":"Major","sequence":"first","affiliation":[{"name":"School of Biological Sciences University of Canterbury  Christchurch New Zealand"},{"name":"Biomolecular Interaction Centre, School of Biological Sciences University of Canterbury  Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Biological Sciences University of Canterbury  Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6696-090X","authenticated-orcid":false,"given":"Eva","family":"van den Berg","sequence":"additional","affiliation":[{"name":"School of Biological Sciences University of Canterbury  Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre L.","family":"Merry","sequence":"additional","affiliation":[{"name":"School of Biological Sciences University of Canterbury  Christchurch New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5195-1901","authenticated-orcid":false,"given":"Angus","family":"Lindsay","sequence":"additional","affiliation":[{"name":"School of Biological Sciences University of Canterbury  Christchurch New Zealand"},{"name":"Biomolecular Interaction Centre, School of Biological Sciences University of Canterbury  Christchurch New Zealand"},{"name":"Department of Medicine University of Otago  Christchurch New Zealand"},{"name":"Maurice Wilkins Centre for Molecular Biodiscovery  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1013077107"},{"issue":"1","key":"e_1_2_6_3_1","first-page":"9","article-title":"Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy","volume":"31","author":"Angelini C.","year":"2012","journal-title":"Acta Myologica"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21327"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001950"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230083"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/brv.12856"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.09.007"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(02)00180-3"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf129"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208112"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26803"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00492.2025"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00248-3"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/00236772231194389"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112123"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2024.102590"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.201010436"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011220"},{"issue":"10","key":"e_1_2_6_20_1","first-page":"1005","article-title":"Efficacy and safety of Vamorolone vs placebo and Prednisone among boys with Duchenne muscular dystrophy: A randomized clinical trial","volume":"79","author":"Guglieri M.","year":"2022","journal-title":"Journal of the American Medical Association Neurology"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/23333936221094858"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201302621"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201800186"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90579-4"},{"issue":"5","key":"e_1_2_6_25_1","first-page":"640","article-title":"Age\u2010related differences in dystrophin: Impact on force transfer proteins, membrane integrity, and neuromuscular junction stability","volume":"72","author":"Hughes D. C.","year":"2017","journal-title":"Journals of Gerontology \u2010 Series A Biological Sciences and Medical Sciences"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.3233\/CH-16195"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","unstructured":"Kourakis S. Timpani C. A. Bagaric R. M. Qi B. Ali B. A. Boyer R. Spiesberger G. Kandhari N. Peterson A. L. Debrincat D. Yates T. J. Yan X. Kuang J. deHaan J. B. Stupka N. Nijagal B. Deveson\u2010Lucas D. Fischer D. &Rybalka E.(2024).Moderate\u2010term dimethyl fumarate treatment reduces pathology of dystrophic skeletal and cardiac muscle in a mouse model. bioRxiv. Available at:http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.07.13.601627","DOI":"10.1101\/2024.07.13.601627"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002500R"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32163-w"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101163RR"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddad173"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac048"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107161"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32160-8"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.47.0907"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1512968112"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI91445"},{"issue":"24","key":"e_1_2_6_38_1","article-title":"Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic\u2010metabolic reprogramming","volume":"4","author":"Quattrocelli M.","year":"2019","journal-title":"Journal of Clinical Investigation Insight"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102700"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303902"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034204"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.049028"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2020.04.015"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn253"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000410"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-4-21"},{"issue":"21","key":"e_1_2_6_47_1","article-title":"Dimethyl fumarate modulates the dystrophic disease program following short\u2010term treatment","volume":"8","author":"Timpani C. A.","year":"2023","journal-title":"Journal of Clinical Investigation Insight"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00602.2009"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56644-w"},{"issue":"6","key":"e_1_2_6_50_1","first-page":"1041","article-title":"Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin\u2010deficient mdx mice","volume":"26","author":"Vaillend C.","year":"2017","journal-title":"Human Molecular Genetics"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2011.10.025"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt112"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-018-0045-4"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246507"}],"container-title":["The Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/physoc.onlinelibrary.wiley.com\/doi\/pdf\/10.1113\/JP291378","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/physoc.onlinelibrary.wiley.com\/doi\/full-xml\/10.1113\/JP291378","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/physoc.onlinelibrary.wiley.com\/doi\/pdf\/10.1113\/JP291378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:35:38Z","timestamp":1785742538000},"score":1,"resource":{"primary":{"URL":"https:\/\/physoc.onlinelibrary.wiley.com\/doi\/10.1113\/JP291378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":53,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1113\/JP291378"],"URL":"https:\/\/doi.org\/10.1113\/jp291378","archive":["Portico"],"relation":{},"ISSN":["0022-3751","1469-7793"],"issn-type":[{"value":"0022-3751","type":"print"},{"value":"1469-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"2026-03-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}